Urinary-free cortisol-based thresholds for differentiating ACTH-dependent Cushing: a Spanish validation study
CONTEXT: Differentiating ectopic ACTH secretion (EAS) from Cushing's disease (CD) remains one of the most challenging steps in the diagnostic workup of ACTH-dependent Cushing's syndrome (CS). Urinary free cortisol (UFC) expressed as times above the upper limit of normal (ULN) has been proposed as a simple, noninvasive discriminator, but external validation in independent populations is lacking. OBJECTIVE: To validate the diagnostic performance of UFC×ULN for distinguishing EAS from CD and to explore complementary biochemical markers, including late-night salivary cortisol (LNSC×ULN) and hypokalemia. DESIGN, SETTING, AND PARTICIPANTS: Multicenter retrospective study from the Spanish Cushing Registry including 269 patients with ACTH-dependent Cushing's syndrome (208 CD, 61 EAS) diagnosed and managed in tertiary referral centers. MAIN OUTCOME MEASURES: Diagnostic accuracy of UFC×ULN and LNSC×ULN for discriminating EAS from CD, expressed as area under the ROC curve (AUC), sensitivity, specificity, and predictive value. RESULTS: EAS patients were older (median 59.0 vs 44.9 years; P<0.001) and showed higher UFC×ULN (16.6 vs 3.6; P<0.001) and LNSC×ULN (9.3 vs 1.5; P<0.001). UFC×ULN and LNSC×ULN achieved excellent discriminative performance (AUC 0.90 and 0.92). No EAS occurred with UFC×ULN < 3×ULN, while 40.5% of patients with UFC ≥ 10×ULN had EAS. The combination of severe hypercortisolism (UFC ≥ 10×ULN and LNSC ≥ 9×ULN) plus hypokalemia identified 75% of EAS with 98% specificity. CONCLUSIONS: UFC×ULN thresholds reliably stratify the probability of EAS versus CD. Severe hypercortisolism and hypokalemia strongly predict EAS, supporting a pragmatic diagnostic approach that prioritizes whole-body imaging in high-risk patients and pituitary-centered evaluation in mild cases.
Authors
- Luis Candil Valero
- Andrés Cardona-Arias
- Rogelio García-Centeno
- Betina Biagetti (ORCID: https://orcid.org/0000-0002-8837-4343)
- David Sanchis-Pascual (ORCID: https://orcid.org/0009-0004-2863-4993)
- Cristina Álvarez-Escolá (ORCID: https://orcid.org/0000-0003-4448-7941)
- María Dolores Moure Rodríguez
- María Dolores Ollero García
- Paola Gracia
- Victoria Alcázar Lázaro
- Pedro Marques
- Miguel Paja
- Marta Araujo-Castro
- Felicia A Hanzu
- Ana Castro
- Claudia Lozano-Aida
- Alfonso Soto-Moreno
- Fernando Guerrero-Pérez
- Cristina Lamas
- Ana Irigaray Echarri
- Laura González-Fernández
Institutions
- Hebron University (PS)
- Instituto Cajal (ES)
- Universidade Católica Portuguesa (PT)
- Hospital Universitario La Paz (ES)
- Bellvitge University Hospital (ES)
- ProMedica Toledo Hospital (US)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- BioCruces Health research Institute (ES)
- Hospital de Basurto (ES)
- Complejo Hospitalario de Navarra (ES)
- Hospital Royo Villanova (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Hospital Clínic de Barcelona (ES)
- Leitat Technological Center (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Hospital Universitario Central de Asturias (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Complejo Hospitalario Universitario de Albacete (ES)
- Hospital Universitario Severo Ochoa (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Hospital do Desterro (PT)
- Instituto de Investigación Sanitaria La Fe (ES)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
- Universidad de Navarra (ES)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-04-30
- DOI
- https://doi.org/10.1210/clinem/dgag187
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00